The effectiveness removes a key overhang — selling stockholders can now trade freely. Monitor for any large block trades or insider selling in the coming days, but the resale registration was expected and already priced in. No new dilution or capital raise is associated with this filing.
Price Chart
Executive Summary
The SEC declared effective Climb Bio's S-3 registration statement (File No. 333-296346) on June 9, 2026. This shelf registration covers the resale of 11,587,000 shares by selling stockholders, including shares from a prior private placement that raised ~$110M. The company receives no proceeds from these resales, but the effectiveness removes a key overhang and allows selling stockholders to trade freely.
Key Facts
- Effectiveness date: June 9, 2026
- Registration covers 11,587,000 shares (9,481,000 outstanding + 2,106,000 pre-funded warrant shares) for resale by selling stockholders
- Shares originated from a private placement on April 27, 2026 that raised ~$110M in gross proceeds
- Company will not receive any proceeds from the resale of shares under this prospectus
- This is a routine resale registration to fulfill contractual registration rights obligations, not a new capital raise
Financial Impact
No new capital raised; potential selling pressure from up to 11.6M shares being registered for resale, but the private placement was already disclosed and priced
Risk Factors
- Potential near-term selling pressure as registered shares become freely tradable
- No new capital raised — company remains dependent on existing cash runway from the April private placement
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001931 |
| Document: 9999999995-26-001931-index.html | 9999999995-26-001931 |
| Document: 9999999995-26-001931.txt | 9999999995-26-001931 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 8-K | — | awaiting T+1 | — | — |
Oct 23, 2026 2d ago | 8-K | $10.47 | awaiting T+1 | — | $8.81 (−15.85%) |
Oct 23, 2026 3d ago | Press Release | $10.34 | awaiting T+1 | — | $8.81 (−14.80%) |
Sep 22, 2026 4w ago | Institutional Cluster | $14.21 $12.52 | ▼ −11.89% | ▼ −11.17% | $8.81 (−38.00%) |
Sep 3, 2026 7w ago | 8-K | $14.59 $15.52 | ▲ +6.37% | ▲ +6.76% | $8.81 (−39.62%) |
Aug 14, 2026 10w ago | 8-K | $16.33 $17.44 | ▲ +6.80% | ▲ +7.27% | $8.81 (−46.05%) |
Aug 6, 2026 11w ago | 8-K | $14.00 $14.00 | · 0.00% | ▼ −0.61% | $8.81 (−37.07%) |
Jun 30, 2026 16w ago | 144 | $13.29 $12.90 | ▼ −2.93% | ▼ −2.80% | $8.81 (−33.71%) |
Jun 12, 2026 19w ago | 8-K | $11.49 $10.71 | ▲ +6.79% | ▲ +6.19% | $8.81 (+23.32%) |
Jun 12, 2026 19w ago | 424B5 | $11.49 $10.71 | ▲ +6.79% | ▲ +6.19% | $8.81 (+23.32%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers